View Older Stories View More Recent Stories

Apr 27, 2021 01:55PM CytoSorbents to Report Q1 2021 Operating and Financial Results
Apr 19, 2021 07:09AM U.S. FDA Approves CytoSorbents (CTSO) to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery
Apr 19, 2021 07:08AM U.S. FDA Approves CytoSorbents to Initiate U.S. STAR-T Trial For Ticagrelor Removal During Cardiothoracic Surgery
Mar 29, 2021 07:08AM CytoSorbents Announces Lease of New Global Headquarters in Princeton, New Jersey
Mar 16, 2021 03:16PM Cytosorbents (CTSO) Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
Mar 16, 2021 03:15PM CytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic Surgery
Mar 12, 2021 07:00AM CytoSorbents to Present at the Oppenheimer 31st Annual Healthcare Conference
Mar 9, 2021 04:15PM CytoSorbents Announces 2020 Financial and Operational Results
Mar 2, 2021 07:00AM B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Mar 1, 2021 06:00PM CytoSorbents to Report Fiscal 2020 Operating and Financial Results
Feb 24, 2021 07:08AM CytoSorbents to Present at the Cowen 41st Annual Health Care Conference
Feb 18, 2021 07:08AM CytoSorbents 2021: Leadership and Growth in the "New Normal"
Feb 16, 2021 07:08AM CytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 4, 2021 07:08AM National Institute for Health and Care Excellence (NICE) Issues Medtech Innovation Briefing on CytoSorb for Reducing Risk of Bleeding During Cardiac Surgery
Jan 21, 2021 07:08AM CytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory Affairs
Jan 19, 2021 07:11AM Cytosorbents (CTSO) Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care
Jan 19, 2021 07:08AM CytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical Care
Jan 12, 2021 07:01AM Cytosorbents (CTSO) Announces Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients
Jan 12, 2021 07:00AM Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients
Jan 12, 2021 06:58AM CytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 Revenue
Jan 11, 2021 06:00AM CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
Jan 4, 2021 06:31AM Cytosorbents (CTSO) Announces Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients
Jan 4, 2021 06:30AM Health Canada Authorizes CytoSorb for Use in Hospitalized COVID-19 Patients
Dec 17, 2020 07:08AM CytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and Marketing
Dec 10, 2020 07:00AM CytoSorbents Pays Off $15M Term Loans and Establishes New Undrawn $15M Loan Commitment with Bridge Bank
Dec 9, 2020 06:48AM Cytosorbents (CTSO) Announces Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study
Dec 9, 2020 06:45AM Early CytoSorb Initiation Improves Hemodynamic Stabilization and Survival in New Septic Shock Study
Dec 2, 2020 07:08AM CytoSorbents Launches International Campaign to Raise $100,000 for the Global Humanitarian Organization, CARE
Nov 25, 2020 07:08AM Cytosorbents (CTSO) Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients
Nov 25, 2020 07:08AM CytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 Patients
Nov 23, 2020 07:00AM CytoSorbents to Present at the Piper Sandler 32nd Annual Healthcare Conference
Nov 12, 2020 02:00AM CytoSorbents to Present at the Jefferies Virtual London Healthcare Conference
Nov 4, 2020 04:15PM CytoSorbents Reports Record Third Quarter 2020 Financial Results
Oct 21, 2020 07:08AM CytoSorbents to Report Q3 2020 Operating and Financial Results
Oct 14, 2020 07:06AM Cytosorbents (CTSO) and Aferetica Announce European Union Approval of PerLife System and ECOS-300CY PerSorb™ Cartridge for Combined Perfusion and Purification of Solid Organs Dedicated to Transplant
Oct 14, 2020 07:00AM CytoSorbents and Aferetica Announce European Union Approval of the PerLife™ System and ECOS-300CY™ PerSorb™ Cartridge for Combined Perfusion and Purification of Solid Organs Dedicated to Transpl
Oct 9, 2020 07:12AM Cytosorbents (CTSO) Secures $1.1M in Defense Awards to Optimize Development of HemoDefend-BGA for Life-saving Universal Plasma
Oct 9, 2020 07:08AM The U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize Development of HemoDefend-BGA™ for Life-saving Universal Plasma
Sep 21, 2020 07:10AM Cytosorbents (CTSO) Annunces CytoSorb Achieves Registration in Brazil and Is Now Commercially Available To Treat Cytokine Storm in COVID-19 Infection and Other Conditions
Sep 21, 2020 07:08AM CytoSorb Achieves Registration in Brazil and Is Now Commercially Available To Treat Cytokine Storm in COVID-19 Infection and Other Conditions
Sep 11, 2020 08:00AM CytoSorbents Highlights CytoSorb Use in Sepsis Patients During Sepsis Awareness Month and World Sepsis Day 2020
Sep 8, 2020 07:08AM CytoSorbents Announces the "CytoSorb Therapy in COVID-19 ICU Patients" (CTC) Registry Is Actively Enrolling
Aug 24, 2020 07:00AM Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19
Aug 17, 2020 07:09AM Cytosorbents (CTSO) Partners with InvoSurg and Surgical Partners to Commercialize CytoSorb in the U.S. Northeast, Mid-Atlantic, and Florida under FDA EUA for COVID-19
Aug 17, 2020 07:08AM CytoSorbents Partners with InvoSurg and Surgical Partners to Commercialize CytoSorb® in the U.S. Northeast, Mid-Atlantic, and Florida under FDA Emergency Use Authorization for COVID-19
Aug 4, 2020 04:15PM CytoSorbents Reports Record Second Quarter 2020 Financial Results
Aug 3, 2020 07:00AM CytoSorbents Achieves Milestone of More than 100,000 CytoSorb Treatments Delivered Cumulatively To Date
Jul 31, 2020 07:11AM Cytosorbents (CTSO) Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
Jul 31, 2020 07:08AM CytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical Development
Jul 28, 2020 07:13AM Cytosorbents (CTSO) Reports REFRESH 2-AKI Trial Data Monitoring Committee has Recommended Study Resumption Following Favorable Review of Safety Data
View More Recent Stories View Older Stories